+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Multiplexed Diagnostics Market by Product (Instruments, Kits And Reagents, Software And Services), Technology (Benchtop Sequencers, High Throughput Sequencers, Immunoassay), Application, End User - Global Forecast 2025-2030- Product Image
Multiplexed Diagnostics Market by Product (Instruments, Kits And Reagents, Software And Services), Technology (Benchtop Sequencers, High Throughput Sequencers, Immunoassay), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Multiplexed Diagnostics Market by Product (Instruments, Kits And Reagents, Software And Services), Technology (Benchtop Sequencers, High Throughput Sequencers, Immunoassay), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968780
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The multiplexed diagnostics market is experiencing rapid transformation, driven by technological advancements and evolving healthcare strategies globally. Senior decision-makers are increasingly seeking actionable market intelligence to optimize investment, navigate trade complexities, and implement precision healthcare solutions at scale.

Market Snapshot: Multiplexed Diagnostics Market Growth and Trends

In 2024, the multiplexed diagnostics market reached a size of USD 17.36 billion and is projected to grow to USD 20.42 billion in 2025, advancing at a compound annual growth rate (CAGR) of 16.78%. The sector’s upward trajectory is expected to continue, aiming for a value of USD 44.05 billion by 2030. Expansion is underpinned by the increasing demand for high-throughput analytical platforms, growing investments in personalized medicine, and the ongoing integration of sophisticated bioinformatics tools that allow simultaneous analysis of multiple biomarkers.

Scope & Segmentation: Multiplexed Diagnostics Market Overview

This report delivers a thorough examination of the multiplexed diagnostics industry’s major segments, global regions, and technology types—enabling actionable insights for strategic planning.

  • Product Categories: Immunoassay analyzers, microarray devices, next generation sequencing instruments, PCR instruments, kits and reagents, software and services.
  • Technology Types: Benchtop sequencers, high throughput sequencers, immunoassays, microarray platforms.
  • Applications: Drug discovery and development, genetic testing, infectious disease diagnostics, oncology.
  • End User Segments: Hospitals and clinics, pharma and biopharma companies, point of care testing providers, reference laboratories.
  • Regional Markets: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key markets such as the UK, Germany, France, Russia, UAE, South Africa, and more), Asia-Pacific (including China, India, Japan, Australia, and several others).
  • Key Companies: Danaher Corporation, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton, Dickinson and Company, QIAGEN N.V., Bio-Rad Laboratories, Inc., PerkinElmer, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC.

Multiplexed Diagnostics Market: Key Takeaways

  • Integration of microfluidic and sequencing technologies is redefining diagnostic workflow efficiency and accuracy, enabling laboratories to scale operations without compromising quality.
  • Adoption of artificial intelligence and machine learning is enhancing data interpretation, providing actionable insights for clinicians and researchers while supporting faster patient stratification.
  • Sustained industry partnerships between instrument manufacturers and software providers are facilitating comprehensive platform solutions and streamlined data management.
  • Segmented product offerings allow providers to address diverse application areas, catering to drug discovery, genetic testing, infectious disease surveillance, and oncology diagnostics.
  • Regional markets exhibit unique adoption patterns and regulatory landscapes, emphasizing the need for tailored strategies that match local healthcare, reimbursement, and procurement priorities.
  • Market leaders are pursuing both organic innovation and acquisitions to maintain competitive differentiation, while emerging companies focus on collaborative development and flexible business models.

Tariff Impact: Assessing 2025 US Trade Policy on Supply Chains

Recent US tariffs have increased supply chain complexity for multiplexed diagnostics, compelling manufacturers to diversify sourcing and invest in localized production. This shift is prompting new supplier relationships and procurement strategies, as organizations seek to maintain price stability and supply continuity. R&D priorities are being recalibrated to deliver modular enhancements and incremental platform improvements, aligning innovation cycles with the new tariff realities.

Methodology & Data Sources

The research utilizes secondary sources such as peer-reviewed journals, industry white papers, and regulatory filings, complemented by structured interviews with market experts and industry executives. Data reconciliation, statistical analysis, and expert validation ensure the integrity and consistency of insights delivered in this report.

Why This Report Matters

  • Delivers strategic clarity for senior decision-makers evaluating investments, expansion opportunities, or technology partnerships within diagnostic markets.
  • Equips organizations with actionable intelligence to mitigate risks from trade shifts and supply chain disruptions while optimizing product portfolios for emerging clinical needs.
  • Provides a regionally nuanced perspective for developing tailored go-to-market and regulatory strategies across global healthcare landscapes.

Conclusion

The multiplexed diagnostics market is poised for sustained, innovation-led growth across diverse clinical and geographic segments. Stakeholders who proactively leverage these insights will strengthen decision-making, capitalize on new opportunities, and drive competitive excellence amid an evolving healthcare environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in point-of-care multiplexed immunoassay panels enabling same-day multi-analyte disease screening in outpatient clinics
5.2. Integration of next-generation sequencing and multiplex PCR workflows for comprehensive pathogen and resistance gene profiling in clinical laboratories
5.3. Development of digital microfluidics-based multiplex detection systems for high-throughput biomarker quantification in personalized medicine
5.4. Regulatory harmonization efforts driving accelerated approval pathways for multiplex diagnostic assays in global health emergencies
5.5. Emergence of AI-driven data analysis platforms enhancing interpretation of complex multiplex assay outputs for precision oncology applications
5.6. Expansion of decentralized multiplex testing solutions addressing chronic disease monitoring in home-based and telehealth settings
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Multiplexed Diagnostics Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Immunoassay Analyzers
8.2.2. Microarray Devices
8.2.3. Next Generation Sequencing Instruments
8.2.4. PCR Instruments
8.3. Kits And Reagents
8.4. Software And Services
9. Multiplexed Diagnostics Market, by Technology
9.1. Introduction
9.2. Benchtop Sequencers
9.3. High Throughput Sequencers
9.4. Immunoassay
9.5. Microarray
10. Multiplexed Diagnostics Market, by Application
10.1. Introduction
10.2. Drug Discovery And Development
10.3. Genetic Testing
10.4. Infectious Diseases
10.5. Oncology
11. Multiplexed Diagnostics Market, by End User
11.1. Introduction
11.2. Hospitals And Clinics
11.3. Pharma & Biopharma
11.3.1. Biopharmaceutical Companies
11.3.2. Pharmaceutical Companies
11.4. Point Of Care Testing
11.5. Reference Laboratories
12. Americas Multiplexed Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Multiplexed Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Multiplexed Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Danaher Corporation
15.3.2. F. Hoffmann-La Roche Ltd
15.3.3. Thermo Fisher Scientific Inc.
15.3.4. Abbott Laboratories
15.3.5. Becton, Dickinson and Company
15.3.6. QIAGEN N.V.
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. PerkinElmer, Inc.
15.3.9. Luminex Corporation
15.3.10. Meso Scale Diagnostics, LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MULTIPLEXED DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MULTIPLEXED DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MULTIPLEXED DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MULTIPLEXED DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 24. MULTIPLEXED DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 25. MULTIPLEXED DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 26. MULTIPLEXED DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MULTIPLEXED DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BENCHTOP SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HIGH THROUGHPUT SEQUENCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY MICROARRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 92. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 93. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 94. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 95. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 102. CANADA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 103. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 104. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 105. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 106. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 107. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 114. MEXICO MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 165. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 166. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 167. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 168. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 169. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 172. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 173. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 176. GERMANY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 177. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 178. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 179. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 180. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 181. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 182. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 183. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 184. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 185. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 188. FRANCE MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 201. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 202. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 203. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 204. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 205. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 206. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 207. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 212. ITALY MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 213. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 214. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 215. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 216. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 217. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 224. SPAIN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 261. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 262. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 263. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 264. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 265. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 272. DENMARK MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 285. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 286. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 287. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 288. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 289. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 290. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 291. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 296. QATAR MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 297. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 298. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 299. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 300. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 301. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 304. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 305. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 306. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 307. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 308. FINLAND MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PHARMA & BIOPHARMA, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 329. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. NIGERIA MULTIPLEXED DIAGNOSTICS MARKET

Samples

Loading
LOADING...

Companies Mentioned

  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • QIAGEN N.V.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Luminex Corporation
  • Meso Scale Diagnostics, LLC

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.42 Billion
Forecasted Market Value ( USD ) by 2030 $ 44.05 Billion
Compound Annual Growth Rate16.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Multiplexed Diagnostics - Global Strategic Business Report - Product Image

Multiplexed Diagnostics - Global Strategic Business Report

  • Report
  • 382 Pages
  • Global
From
High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report - Product Image

High-Density Multiplexed Diagnostic Assays - Global Strategic Business Report

  • Report
  • 158 Pages
  • Global
From
Multiplexed Diagnostics Market 2025-2029 - Product Image

Multiplexed Diagnostics Market 2025-2029

  • Report
  • 235 Pages
  • Global
From
Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030 - Product Image

Syndromic Multiplex Diagnostics Market Size, Share & Trends Analysis Report By Type (Respiratory, Gastrointestinal, Central Nervous System), By End Use (Hospitals, Diagnostic Laboratories, Others), By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.